Healthcare -
Biotechnology - NASDAQ - US
$ 4.725
-3.77 %
$ 214 M
Market Cap
-7.05
P/E
YMAB - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative YMAB - Y-mAbs Therapeutics, Inc.
54.6 M
LAST VALUE
-5.30%
2 YEAR CAGR
22.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR